Trial

Zacks Small Cap Research – ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements – Go Health Pro

by
Zacks Small Cap Research – ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements – Go Health Pro

By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Planning Phase 3 Oral Insulin study under revised protocol, new CRO agreement in place Oramed Pharmaceuticals (NASDAQ:ORMP) has pivoted its clinical R&D focus to prioritize studying ORMD 0801 for subpopulations of patients with pooled specific parameters who responded well to oral insulin in its prior … Read more

Zacks Small Cap Research – FBLG: On Target to Initiate Phase 1/2 Trial in 2025… – Go Health Pro

by

By David Bautz, PhD NASDAQ:FBLG READ THE FULL FBLG RESEARCH REPORT Business Update On Track to Initiate Phase 1/2 Trial in Diabetic Foot Ulcers FibroBiologics, Inc. (NASDAQ:FBLG) is on track to initiate a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers (DFU) in the second quarter … Read more

Jury Awards Baltimore $266 Million in Damages After Opioid Trial – Go Health Pro

by
Jury Awards Baltimore 6 Million in Damages After Opioid Trial – Go Health Pro

A jury has awarded the city of Baltimore $266 million in damages in its suit against pharmaceutical firms McKesson and AmerisourceBergen for their part in the city’s opioid epidemic. With the jury award, the city has notched another win for its strategy of opting out of a national opioid settlement and pursuing opioid cases on … Read more

In EU embezzlement trial, French far-right leader Le Pen answers questions about aides – Go Health Pro

by
In EU embezzlement trial, French far-right leader Le Pen answers questions about aides – Go Health Pro

French far-right leader Marine Le Pen strongly denied committing any wrongdoing at a Paris court on Monday as she and her National Rally party stand trial over the suspected embezzlement of European Parliament funds. The nine-week trial is a critical juncture for Le Pen, expected to be a strong contender in France’s next presidential election … Read more

Zacks Small Cap Research – AI from EVAX Improves Trial Results – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more